+86-27-65522453 sales@sun-shinechem.com

BGP-15

Catalog No.: 17109003
Cas No.: 66611-37-8
Purity : 98% 
17109003 - BGP-15 | CAS 66611-37-8

Catalog number : 17109003

CAS number : 66611-37-8

Molecular Formula : C14H22N4O2.2HCl 

Molecular Weight : 351.27 

Iupac Chemical Name : BGP-15 

Smile : c1cc(cnc1)C(=N)NOCC(CN2CCCCC2)O

InChiKey : MVLOQULXIYSERZ-UHFFFAOYSA-N

PackagingPriceAvailabilityPurityEstimated Shipping Time
BulkEnquiryEnquiry
Request Bulk Quote Download MSDSTel:+86-27-65522453 | Email:sales@sun-shinechem.com
SynonymsN/A 
Molecular FormulaC14H22N4O2.2HCl 
Molecular Weight351.27 
Appearancecrystalline solid 
Purity98% 
SolubilitySoluble in DMSO 
Storage3 years -20ºCpowder 
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. 
Smilec1cc(cnc1)C(=N)NOCC(CN2CCCCC2)O
InChiKeyMVLOQULXIYSERZ-UHFFFAOYSA-N
InChiInChI=1S/C14H22N4O2/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18/h4-6,9,13,19H,1-3,7-8,10-11H2,(H2,15,17)
MDLMFCD06407909
Coming soon.

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

BGP-15 improves cardiac function and reduces arrhythmic episodes in two independent mouse models, which progressively develop HF and AF. BGP-15 administered in 100-200 mg/kg oral doses shortly before cisplatin treatment either prevented or significantly inhibited the development of cisplatin-induced acute renal failure. BGP-15 had a significant effect on the antioxidant status of kidney during cisplatin-induced nephrotoxicity. It elevated the decreased glutathione and catalase levels, but did not affect SOD activity. BGP-15 treatment decreased the cisplatin-caused ROS production and restored the level of high energy phosphate intermediates. While BGP-15 protected against cisplatin-induced nephrotoxicity, it did not reduce the antitumor efficacy of this cytostatic agent. BGP-15 increased the survival of cisplatin-treated P-388 leukemia bearing mice. BGP-15 inhibits the cisplatin-induced poly-ADP-ribosylation in the kidney. At the same time, BGP-15 restored the cisplatin-induced disturbance in energy metabolism and preserved the ATP level in the protected tissue.

 

66611-37-8 - Request Bulk Quote

×
66611-37-8 - Request Bulk Quote
Change